Brünner N - Search Results

1

High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer.

Nordengren J, Fredstorp Lidebring M, Bendahl PO, Brünner N, Fernö M, Högberg T, Stephens RW, Willén R, Casslén B. Nordengren J, et al. Among authors: brunner n. Int J Cancer. 2002 Jan 20;97(3):379-85. doi: 10.1002/ijc.1611. Int J Cancer. 2002. PMID: 11774293

2

Prognostic importance of the soluble plasminogen activator receptor, suPAR, in plasma from rectal cancer patients.

Fernebro E, Madsen RR, Fernö M, Brünner N, Bendahl P, Christensen IJ, Johnson A, Nilbert M. Fernebro E, et al. Among authors: brunner n. Eur J Cancer. 2001 Mar;37(4):486-91. doi: 10.1016/s0959-8049(00)00422-6. Eur J Cancer. 2001. PMID: 11267858

3

Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer.

Fredstorp-Lidebring M, Bendahl PO, Brünner N, Casslén B, Högberg T, Långström-Einarsson E, Willén R, Fernö M. Fredstorp-Lidebring M, et al. Among authors: brunner n. Eur J Cancer. 2001 Dec;37(18):2339-48. doi: 10.1016/s0959-8049(01)00306-9. Eur J Cancer. 2001. PMID: 11720826

4

Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.

Look MP, van Putten WL, Duffy MJ, Harbeck N, Christensen IJ, Thomssen C, Kates R, Spyratos F, Fernö M, Eppenberger-Castori S, Sweep CG, Ulm K, Peyrat JP, Martin PM, Magdelenat H, Brünner N, Duggan C, Lisboa BW, Bendahl PO, Quillien V, Daver A, Ricolleau G, Meijer-van Gelder ME, Manders P, Fiets WE, Blankenstein MA, Broët P, Romain S, Daxenbichler G, Windbichler G, Cufer T, Borstnar S, Kueng W, Beex LV, Klijn JG, O'Higgins N, Eppenberger U, Jänicke F, Schmitt M, Foekens JA. Look MP, et al. Among authors: brunner n. J Natl Cancer Inst. 2002 Jan 16;94(2):116-28. doi: 10.1093/jnci/94.2.116. J Natl Cancer Inst. 2002. PMID: 11792750 Free article.

5

Prognostic significance of soluble urokinase plasminogen activator receptor in serum and cytosol of tumor tissue from patients with primary breast cancer.

Riisbro R, Christensen IJ, Piironen T, Greenall M, Larsen B, Stephens RW, Han C, Høyer-Hansen G, Smith K, Brünner N, Harris AL. Riisbro R, et al. Among authors: brunner n. Clin Cancer Res. 2002 May;8(5):1132-41. Clin Cancer Res. 2002. PMID: 12006529

6

Association between tumor tissue TIMP-1 levels and objective response to first-line chemotherapy in metastatic breast cancer.

Klintman M, Ørnbjerg Würtz S, Christensen IJ, Braemer Hertel P, Fernö M, Malmberg M, Mouridsen H, Cold F, Schrohl AS, Foekens JA, Malmström P, Brünner N. Klintman M, et al. Among authors: brunner n. Breast Cancer Res Treat. 2010 Jun;121(2):365-71. doi: 10.1007/s10549-009-0483-1. Epub 2009 Aug 4. Breast Cancer Res Treat. 2010. PMID: 19653096

7

The urokinase plasminogen activator system as a target for prognostic studies in breast cancer.

Stephens RW, Brünner N, Jänicke F, Schmitt M. Stephens RW, et al. Among authors: brunner n. Breast Cancer Res Treat. 1998;52(1-3):99-111. doi: 10.1023/a:1006115218786. Breast Cancer Res Treat. 1998. PMID: 10066075 Review.

8

High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer.

Holten-Andersen MN, Stephens RW, Nielsen HJ, Murphy G, Christensen IJ, Stetler-Stevenson W, Brünner N. Holten-Andersen MN, et al. Among authors: brunner n. Clin Cancer Res. 2000 Nov;6(11):4292-9. Clin Cancer Res. 2000. PMID: 11106246

9

The complex between urokinase and its type-1 inhibitor in primary breast cancer: relation to survival.

Pedersen AN, Christensen IJ, Stephens RW, Briand P, Mouridsen HT, Danø K, Brünner N. Pedersen AN, et al. Among authors: brunner n. Cancer Res. 2000 Dec 15;60(24):6927-34. Cancer Res. 2000. PMID: 11156392

10

S-phase fraction and urokinase plasminogen activator are better markers for distant recurrences than Nottingham Prognostic Index and histologic grade in a prospective study of premenopausal lymph node-negative breast cancer.

Malmström P, Bendahl PO, Boiesen P, Brünner N, Idvall I, Fernö M; South Sweden Breast Cancer Group. Malmström P, et al. Among authors: brunner n. J Clin Oncol. 2001 Apr 1;19(7):2010-9. doi: 10.1200/JCO.2001.19.7.2010. J Clin Oncol. 2001. PMID: 11283134

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

594 results

Search Page

Filters